Visual function-specific perimetry to identify glaucomatous visual loss using three different definitions of visual field abnormality.

PURPOSE To compare the most recent versions of standard automated perimetry (SAP), short-wavelength automated perimetry (SWAP), and frequency-doubling technology (FDT) using three definitions of visual field (VF) abnormality: single-test abnormality, abnormality confirmed by the same test, and abnormality confirmed by a different test. METHODS Data obtained from one eye of each of 174 patients with glaucoma and 164 age-matched healthy control subjects from the Diagnostic Innovations in Glaucoma Study and African Descent and Glaucoma Evaluation Study were included, based on the appearance of the optic disc on stereophotographs. Each participant had two reliable 24-2 SAP-SITA, SWAP-SITA, and Matrix FDT tests. Receiver operating characteristic (ROC) curves were generated for the PSD of each test to equate the tests at 90% and 95% specificity. SAP, SWAP, and FDT were compared under each definition of VF abnormality by assessing the sensitivities, the agreement between tests and the overlap in deficit location at these set specificities. The tests were also compared using the machine-derived PSD. RESULTS At a set specificity of 95%, single-test sensitivities of 30% (SAP), 29% (SWAP), and 28% (FDT) were observed (all P > 0.05). Sensitivities ranged from 24% to 27% (all P > 0.05) when same-test confirmation was used and from 20% to 23% (all P > 0.05) when different-test confirmation was used. SAP/SAP sensitivity was higher than all different-test combinations (all P < 0.05), and SWAP/FDT sensitivity was lower than all same-test combinations (all P < 0.05). CONCLUSIONS Confirming VF abnormality is important and optimal when an abnormal SAP is confirmed by a subsequent SAP or SWAP test.

[1]  Chris A. Johnson,et al.  Evaluation of Decision Rules for Frequency-Doubling Technology Screening Tests , 2006, Optometry and vision science : official publication of the American Academy of Optometry.

[2]  Joseph San Laureano When is glaucoma really glaucoma , 2007 .

[3]  R. Anderson The psychophysics of glaucoma: Improving the structure/function relationship , 2006, Progress in Retinal and Eye Research.

[4]  C. Johnson,et al.  Short-wavelength automated perimetry in low-, medium-, and high-risk ocular hypertensive eyes. Initial baseline results. , 1995, Archives of ophthalmology.

[5]  P A Sample,et al.  Color perimetry for assessment of primary open-angle glaucoma. , 1990, Investigative ophthalmology & visual science.

[6]  D. H. Kelly Frequency Doubling in Visual Responses , 1966 .

[7]  Chris A. Johnson,et al.  Mechanisms isolated by frequency-doubling technology perimetry. , 2002, Investigative ophthalmology & visual science.

[8]  Boel Bengtsson,et al.  A new rapid threshold algorithm for short-wavelength automated perimetry. , 2003, Investigative ophthalmology & visual science.

[9]  H. Rootzén,et al.  A new generation of algorithms for computerized threshold perimetry, SITA. , 2009, Acta ophthalmologica Scandinavica.

[10]  H. Quigley Identification of glaucoma-related visual field abnormality with the screening protocol of frequency doubling technology. , 1998, American journal of ophthalmology.

[11]  Chris A. Johnson,et al.  Structure and function evaluation (SAFE): II. Comparison of optic disk and visual field characteristics. , 2003, American journal of ophthalmology.

[12]  Barry B. Lee,et al.  An examination of physiological mechanisms underlying the frequency-doubling illusion. , 2002, Investigative ophthalmology & visual science.

[13]  C. Johnson,et al.  Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss. , 1993, Archives of ophthalmology.

[14]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[15]  P. Sample,et al.  Short-wavelength automated perimetry. , 2003, Ophthalmology clinics of North America.

[16]  C. Johnson,et al.  Screening for glaucomatous visual field loss with frequency-doubling perimetry. , 1997, Investigative ophthalmology & visual science.

[17]  Robert N Weinreb,et al.  Identifying glaucomatous vision loss with visual-function-specific perimetry in the diagnostic innovations in glaucoma study. , 2006, Investigative ophthalmology & visual science.

[18]  Ted Maddess,et al.  Performance of nonlinear visual units in ocular hypertension and glaucoma , 1992 .

[19]  Chris A. Johnson,et al.  Performance of efficient test procedures for frequency-doubling technology perimetry in normal and glaucomatous eyes. , 2002, Investigative ophthalmology & visual science.

[20]  J L Keltner,et al.  Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group. , 2000, Archives of ophthalmology.

[21]  P A Sample,et al.  Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma. , 2000, Investigative ophthalmology & visual science.

[22]  Robert N Weinreb,et al.  Diagnostic accuracy of the Matrix 24-2 and original N-30 frequency-doubling technology tests compared with standard automated perimetry. , 2008, Investigative ophthalmology & visual science.

[23]  C. Johnson Selective versus nonselective losses in glaucoma. , 1994, Journal of glaucoma.

[24]  A. James,et al.  Evidence for spatial aliasing effects in the Y-like cells of the magnocellular visual pathway , 1998, Vision Research.

[25]  B. Chauhan,et al.  Longitudinal changes in the visual field and optic disc in glaucoma , 2005, Progress in Retinal and Eye Research.

[26]  A. James,et al.  Testing for glaucoma with the spatial frequency doubling illusion , 1999, Vision Research.

[27]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[28]  A Heijl,et al.  Early Manifest Glaucoma Trial: design and baseline data. , 1999, Ophthalmology.

[29]  A J Adams,et al.  Optimum Parameters for Short‐Wavelength Automated Perimetry , 1996, Journal of glaucoma.